Wall Street’s record-setting rally is due for a reality check, according to the latest report from Stifel’s Barry Bannister ...

Shares of Excelerate Energy slipped after the company's second-quarter profit fell, hurt by costs tied to a recent acquisition, and its top line missed estimates. The stock fell 4.1%, to $23.33, ...

If I understand correctly, Roth conversions are good when you expect tax rates to rise. With the new GOP tax law just passed, ...

Shares of Tiziana Life Sciences gained after the biotechnology company said the Food & Drug Administration approved the investigational new drug application for a trial of its treatment for multiple ...

Investors will be looking closely at consumer-price index data due Tuesday and producer-price index data due Thursday. The ...

People with certain serious health conditions now on the “Compassionate Allowances” list may receive benefits more quickly.

Some of the biggest names in cannabis saw similar gains. Shares of Curaleaf Holdings were up 20%, at $2.46, helping it become the biggest U.S. cannabis company by market capitalization. Green Thumb ...

Shares of Compass Therapeutics rose after the biopharmaceutical company reported better-than-expected survival data from its continuing study of a cancer drug. The stock was up 16%, to $3.15, and have ...

ESPN and Fox said they would offer a bundle of their streaming services starting October 2.

The declines come as markets await the outcome of Friday's meeting between President Trump and Russian President Vladimir Putin, given that an agreement to end the war between Russia and Ukraine would ...

I-Mab shares were 13% higher, at $3.84, after the company said enrollment in its planned Phase 1b dose expansion cohorts evaluating givastomig in combination with nivolumab and mFOLFOX6 has been ...